Keros Therapeutics Inc

KROS NASDAQ Santé & Biotech États-Unis US4923271013
10.65 $
2.31 %

Keros Therapeutics développe des thérapies pour les maladies hématologiques et les disorders musculosquelettiques.

Performance & Momentum

6 Months 47.89 %
1 Year 22.58 %
3 Years 73.41 %
5 Years 80.49 %

Similar stocks to Keros Therapeutics Inc

Anantys Community

Be the first to share your analysis on Keros Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases